These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20073404)

  • 1. [The role of hypoxia and HIF-mediated hypoxia adaptive response in the progression of chronic kidney disease].
    Khamaisi M; Heyman SN
    Harefuah; 2009 Oct; 148(10):721-6, 732. PubMed ID: 20073404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease.
    Heyman SN; Khamaisi M; Rosen S; Rosenberger C
    Am J Nephrol; 2008; 28(6):998-1006. PubMed ID: 18635927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hypoxia in the pathogenesis of renal disease.
    Eckardt KU; Bernhardt WM; Weidemann A; Warnecke C; Rosenberger C; Wiesener MS; Willam C
    Kidney Int Suppl; 2005 Dec; (99):S46-51. PubMed ID: 16336576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis.
    Tanaka T; Matsumoto M; Inagi R; Miyata T; Kojima I; Ohse T; Fujita T; Nangaku M
    Kidney Int; 2005 Dec; 68(6):2714-25. PubMed ID: 16316346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrarenal oxygenation in chronic renal failure.
    Norman JT; Fine LG
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):989-96. PubMed ID: 17002678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute-on-chronic renal failure in the rat: functional compensation and hypoxia tolerance.
    Goldfarb M; Rosenberger C; Abassi Z; Shina A; Zilbersat F; Eckardt KU; Rosen S; Heyman SN
    Am J Nephrol; 2006; 26(1):22-33. PubMed ID: 16508244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic strategy with hypoxia-inducible factors via reversible epigenetic regulation mechanisms in progressive tubulointerstitial fibrosis.
    Mimura I; Tanaka T; Nangaku M
    Semin Nephrol; 2013 Jul; 33(4):375-82. PubMed ID: 24011579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms in remodeling of the kidney].
    Nangaku M; Miyata T
    Nihon Rinsho; 2008 Sep; 66(9):1696-700. PubMed ID: 18788396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of renoprotective gene expression by hypoxia-inducible transcription factor-1alpha ameliorates renal damage.
    Wang W; Zhang J
    Med Hypotheses; 2008; 70(5):948-50. PubMed ID: 18031944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.
    Nangaku M
    J Am Soc Nephrol; 2006 Jan; 17(1):17-25. PubMed ID: 16291837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia.
    Rosenberger C; Heyman SN; Rosen S; Shina A; Goldfarb M; Griethe W; Frei U; Reinke P; Bachmann S; Eckardt KU
    Kidney Int; 2005 Feb; 67(2):531-42. PubMed ID: 15673301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.
    Yu X; Fang Y; Liu H; Zhu J; Zou J; Xu X; Jiang S; Ding X
    Nephrol Dial Transplant; 2012 Aug; 27(8):3110-9. PubMed ID: 22399494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The signaling pathway of hypoxia inducible factor and its role in renal diseases.
    Mao S; Huang S
    J Recept Signal Transduct Res; 2013 Dec; 33(6):344-8. PubMed ID: 23971630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics.
    Fine LG; Norman JT
    Kidney Int; 2008 Oct; 74(7):867-72. PubMed ID: 18633339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation to hypoxia in the diabetic rat kidney.
    Rosenberger C; Khamaisi M; Abassi Z; Shilo V; Weksler-Zangen S; Goldfarb M; Shina A; Zibertrest F; Eckardt KU; Rosen S; Heyman SN
    Kidney Int; 2008 Jan; 73(1):34-42. PubMed ID: 17914354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of hypoxia-inducible transcription factors in polycystic kidney disease.
    Bernhardt WM; Wiesener MS; Weidemann A; Schmitt R; Weichert W; Lechler P; Campean V; Ong AC; Willam C; Gretz N; Eckardt KU
    Am J Pathol; 2007 Mar; 170(3):830-42. PubMed ID: 17322369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial cell polarity and hypoxia influence heme oxygenase-1 expression by heme in renal epithelial cells.
    Basireddy M; Lindsay JT; Agarwal A; Balkovetz DF
    Am J Physiol Renal Physiol; 2006 Oct; 291(4):F790-5. PubMed ID: 16622174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease.
    Mimura I; Nangaku M
    Nat Rev Nephrol; 2010 Nov; 6(11):667-78. PubMed ID: 20877304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of chronic hypoxia-induced renal cell growth.
    Sahai A; Mei C; Schrier RW; Tannen RL
    Kidney Int; 1999 Oct; 56(4):1277-81. PubMed ID: 10504474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of CKD: a look into the future.
    Khwaja A; El Kossi M; Floege J; El Nahas M
    Kidney Int; 2007 Dec; 72(11):1316-23. PubMed ID: 17700639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.